Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 14, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Maintained (ANVS) at Strong Buy with Decreased Target to $23 on, May 13th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Annovis Bio, Inc." (ANVS) at Strong Buy with Decreased Target from $30 to $23 on, May 13th, 2024.
Raghuram has made no other calls on ANVS in the last 4 months.
There are 2 other peers that have a rating on ANVS. Out of the 2 peers that are also analyzing ANVS, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tyler Bussian of "Brookline Capital" Downgraded from Strong Buy to Hold and Held Target at $9 on, Wednesday, February 28th, 2024
This is the rating of the analyst that currently disagrees with Raghuram
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, April 30th, 2024
